Guggenheim analyst Michael Schmidt downgrades Arvinas (NASDAQ:ARVN) from Buy to Neutral.
Guggenheim Downgrades Arvinas to Neutral
Guggenheim analyst Michael Schmidt downgrades Arvinas (NASDAQ:ARVN) from Buy to Neutral.
Related Posts
4 Analysts Have This to Say About Evofem Biosciences
Over the past 3 months, 4 analysts have published their opinion on Evofem Biosciences (OTC:EVFM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Analyst Ratings for Harley-Davidson
Harley-Davidson (NYSE:HOG) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Weed Trafficking Plot: California Co. Sues Competitor Over Alleged Black Market Profiteering
A California cannabis company has been accused of transporting and shipping cannabis across state lines on airplanes, according to a lawsuit filed by one of its competitors,